The characteristics of the gastric microbiota in patients with gastric polyposis (GP) remain unclear. Given this we collected gastric antrum and gastric body biopsies from healthy controls (HC.A and HC.B group) and gastric antrum, gastric body and polyp biopsies from patients with multiple gastric polyps (GP.A, GP.B and GP.P group) for 16S rDNA sequencing. The results showed that the diversity of the gastric flora in the GP group was significantly lower than that of the HC group. The gastric flora composition of the GP group was significantly different from the HC group. However, flora diversity and compositions in different parts of the stomach (gastric antrum, gastric body or polyp tissue) were not significantly different. H. pylori abundance could influence the composition of gastric microbiota. Meanwhile, patients with fundic gland polyps (FGPs) and those with hyperplastic polyps (HPs) had considerably similar gastric bacterial compositions. We constructed a microbial dysbiosis index (MDI) based on the gastric microbiota at the genus level as a predictive model, and it was able to distinguish between individuals in the GP and HC groups. These findings showed that intragastric flora dysbiosis may be closely related to the occurrence and development of gastric polyps.
Gastric polyps are limited epithelial protrusions of the epithelial mucosa, and the most common pathological types are gastric fundic gland polyps (FGPs) and hyperplastic polyps (HPs)1,2. While their overall prevalence appears to have increased in the past thirty years3, the diagnosis and treatment of gastric polyps have attracted attention. However, their etiology, biological characteristics and long-term impact on the body remain unclear. There are many potential factors associated with the development of gastric polyps, including genes, bile reflux, Helicobacter pylori infection, and long-term use of proton pump inhibitors (PPIs)4,5. However, direct evidence for the involvement of these factors is lacking, and there is little new information regarding gastric polyps. In recent years, studies of microbial and human health and disease have begun to use metagenomic principles and high-throughput sequencing analysis, which have become popular research tools. However, most studies are based on gut microbe and focus on the relationship between gut microbes and intestinal and metabolic diseases. Few researchers have paid attention to the role of the microbiota in gastric diseases. The stomach is a special area with regards to the gastrointestinal microbiota, as it has its own unique ecological environment and characteristic microbial communities due to the secretion of gastric acid. Several existing studies on intragastric flora based on high-throughput sequencing have confirmed the existence of complex flora in the stomach6,7. According to these studies, there are large numbers of other microorganisms in addition to H. pylori in the stomach. In addition, gastric microbial dysbiosis plays an important role in gastric carcinogenesis7, but no studies have investigated the relationship between gastric polyps and the stomach flora. Some studies have confirmed that the intestinal flora and diversity in patients with colorectal cancer and colon polyps are altered, and the occurrence and development of colorectal cancer may be related to the intestinal flora8,9. More remarkable, one recent study showed an unexpected link between early colon neoplasia and tumorigenic bacteria based on patients with familial adenomatous polyposis10. However, we still do not know much about the characteristics of the gastric flora in patients with gastric polyps and their differences from those in healthy people.
In this study, we analyzed the gastric bacterial community composition and diversity characteristics of patients with gastric polyps. In addition, we constructed a microbial dysbiosis index (MDI) model which was able to predict gastric polyps based on the bacterial profiles of gastric.
A total of 30 HCs and 30 GP patients were included in the study. The age and sex of the subjects were not significantly different between the two groups (P > 0.05) (Supplementary Table 1). In total, 148 eligible gastric mucosal biopsy samples were included in this study (Supplementary Table 2), including 30 gastric antrum samples (HC.A) and 29 gastric body samples (HC.B) from individuals in the HC group and 30 gastric antrum tissues (GP.A), 29 gastric body tissues (GP.B) and 30 gastric polyp tissues (GP.P) from patients in the GP group. The polyp tissues of the 30 patients with multiple gastric polyps were divided into two subgroups according to the pathological polyp type: 20 FGPs and 10 HPs. The infection rates of H. pylori as determined by a rapid urea test (RUT) in the different groups are shown in Supplementary Table 3. None of the healthy subjects were positive for H. pylori by RUT. In the GP group, the H. pylori infection rate was 15.4% (4/26). Moreover, H. pylori was detected by sequencing in all samples, and all subjects in both groups were positive for H. pylori based on this testing method. The mean value of H. pylori relative abundance was 0.139 ± 0.210 in the HC group and 0.0627 ± 0.208 in the GP group (P < 0.05).
The general composition of the gastric mucosal-associated bacterial microbiota
Libraries were constructed for all samples by amplification of the V4 region of the bacterial 16S rDNA gene. A total of 4,558,009 raw reads were obtained after quality filtering, with an average of 30,797 for each sample. A total of 68 bacterial phyla were identified in all gastric biopsy samples. To analyze the difference in the gastric mucosal flora at different sites, we divided the samples into the HC.A, HC.B, GP.A, GP.B and GP.P groups. The dominant bacteria at the phyla level of these five groups were similar. The most common phyla in the stomach are shown in Fig. 1A, and they accounted for 98% of the sequencing data. The top ten phyla included Proteobacteria, Firmicutes, Cyanobacteria, Bacteroidetes, Actinobacteria, Fusobacteria, Acidobacteria, Planctomycetes, Verrucomicrobia and Chloroflexi. The HC tissue groups had a much higher abundance of Proteobacteria but a lower abundance of Firmicutes, Bacteroidetes, Actinobacteria, Fusobacteria and Acidobacteria (Supplementary Table 4).
Furthermore, 598 genera were identified in the stomach, and the top ten were Helicobacter, Streptococcus, Halomonas, Prevotella, Neisseria, Acinetobacter, Shewanella, Veillonella, Rothia, and Fusobacerium (Fig. 1B). In addition, we detected significantly different core genera in at least 70% of the samples, and the p values were less than 0.05 by variance analysis among these five groups, as shown in the core genus heatmap (Fig. 1C), and their relationships are shown in the network figure (Fig. 1D) conducted with spearman rank correlation coefficient. The network figure exhibited an antagonistic relationship between HC-enriched genera and GP-enriched genera, and a synergistic relationship among HC-enriched genera or among GP-enriched genera. Moreover, GP-enriched and HC-depleted genera included Veillonella, Prevotella, Lactobacillus, Streptococcus, Fusobacterium, Rothia, Bacteroides, Actinomyces, Halomonas, and Shewanella, while GP-depleted and HC-enriched genera included Helicobacter, Acinetobacter, Sphingobium, Pseudomonas, Nitrospira and Rhodococcus (Fig. 2).
Alpha diversity of the gastric bacterial microbiota in different groups
The average OTU numbers were 1,151 ± 338, 1,108 ± 336, 688 ± 277, 653 ± 360, and 674 ± 283 in the HC.A, HC.B, GP.A, GP.B and GP.P groups, respectively. The diversity of the gastric bacterial microbiota in the HC.A and HC.B groups was similar, as was that in the GP.A, GP.B and GP.P groups. However, the gastric bacterial diversity in the GP tissue groups was significantly lower than that of the HC tissue groups as measured by observed OTUs and the Shannon diversity index (Fig. 3A,B).
Beta diversity of the gastric bacterial microbiota in different groups
Non-metric multidimensional scaling (NMDS) analysis and weighted and unweighted Principal Coordinates Analysis (PCoA) indicated that the HC and GP groups clustered separately in terms of gastric microbiota composition. The HC.A and HC.B groups showed similar gastric microbiota compositions, as did the GP.A, GP.B and GP.P groups (Fig. 4 and Supplementary Fig. S1). However, the similarity between the HC.A and HC.B groups was much higher than the similarity among the GP.A, GP.B and GP.P groups (Fig. 5A); and weighted and unweighted unifrac distance showed that there was a larger degree of intra-subject variability in gastric bacterial diversity (which means the differences of gastric bacterial diversity among the subjects who are in the same group) among GP patients than in healthy subjects (Fig. 5B,C). In addition, we analyzed the gastric bacterial composition of patients with FGPs and those with HPs. NMDS analysis and unweighted PCoA could not distinguish the two groups significantly, while weighted PCoA showed a considerable difference between the two groups (Fig. 6A,B and Supplementary Figs S2 and S3).
The influence of H. pylori on the diversity and composition of the bacterial microbiota in the stomach
In a previous study, gastric mucosal biopsies with <1% H. pylori abundance were classified as H. pylori-negative, while >1% were classified as H. pylori-positive7. However, this cutoff value of H. pylori sequence percentage was based on clinically positive H. pylori status11. And there were still H. pylori sequence in those H. pylori-negative samples. As we will explore the influence of H. pylori according to its sequences, we classified the samples into two groups: H. pylori-low group (H. pylori abundance <1%), and H. pylori-high group (H. pylori abundance ≥1%). NMDS analysis and weighted and unweighted PCoA showed that the gastric microbiota composition was significantly different between subjects with high H. pylori abundance and subjects with low H. pylori abundance (Fig. 7 and Supplementary Fig. S4). The H. pylori-high group had a much higher abundance of Proteobacteria and Nitrospirae, but a lower abundance of Firmicutes and Fusobacteria than H. pylori-low group in phylum level (Supplementary Fig. S5). And in genera level, the abundances of Helicobacter, Acinetobacter, Zoogloea and Sphingobium were much higher in H. pylori-high group, while the abundances of Shewanella, Bacteroides, Hydrogenophilus and Lactobacillus were much higher in H. pylori-low group (Supplementary Fig. S6). In addition, we investigated the effect of H. pylori on the distinction of FGP and HP, and the results showed that these two groups could not be distinguished based on the H. pylori abundance (Supplementary Figs S7 and S8).
The microbial dysbiosis index as a predictive model
To illustrate the diagnostic value of the gastric mucosal-associated bacterial microbiota in GP, we constructed a microbial dysbiosis index (MDI) model based on genera appeared in 70% (104/148) of all the samples. The performance of the predictive model was defined as the log of [total abundance of the core genera increased in the HC group relative to the GP group] over [total abundance of the core genera decreased in the HC group relative to the GP group]12, using the core genera increased in the HC group, including Helicobacter and Acinetobacter, and the core genera decreased in the HC group, including Prevotella, Streptococcus, Veillonella, Neisseria, Halomonas, and Shewanella (Fig. 8A). The core genera that were significantly different between the HC and GP groups were chosen from the top ten genera in terms of abundance. This model could distinguish between the HC and GP groups. However, it could not distinguish between the HC.A and HC.B tissue groups or between the GP.A, GP.B and GP.P tissue groups (Fig. 8A). In general, the predictive model constructed by the MDI exhibited a high discriminatory potential in the discovery analysis of the HC and GP groups, with an AUC of 91.8% (Fig. 8B). We then verified this index using the rest 30% samples (44/148) and the accuracy is 93.2%, the precision is 100% and recall is 88%.
In recent years, high-throughput sequencing and bioinformatics analysis technology have been used to study various parts of the human body, especially the structure and function of microbial communities in the digestive tract, while only a few studies have evaluated the microbial communities in the stomach. It was traditionally thought that the human stomach was not suitable for the growth and reproduction of microorganisms due to the presence of gastric acid and other antimicrobial agents. With the discovery of H. pylori and other Helicobacter species in the stomach, and the application of high-throughput sequencing in recent years, the study of gastric flora has confirmed that the stomach is a special microbial environment, similar to the gut13. However, in recent years, research on intragastric flora has mainly focused on the changes in the intragastric flora in gastric cancer, atypical hyperplasia, intraepithelial neoplasia and other precancerous lesions. Explorations of the composition of the gastric flora and the pathogenesis of gastric polyps from the perspective of gastrointestinal microecology have not been reported. The present study attempted to characterize the gastric mucosal bacterial microbiota in GP, to identify the significant related phylotypes and to construct a predictive model for the diagnosis of GP based on bacterial markers.
Our study found that patients with gastric polyps and healthy people had similar dominant bacteria at the phylum level, with the top phyla being Proteobacteria, Firmicutes, Cyanobacteria, Bacteroidetes and Actinobacteria; this result was partly consistent with one previous study showing that the majority of sequences in the gut microbiome were assigned to the Proteobacteria, Firmicutes, Actinobacteria, Bacteroidetes and Fusobacteria phyla14. At the genus level, Helicobacter, Streptococcus, Prevotella, Neisseria, Rothia, and Fusobacterium were highly abundant, which is similar to previous studies14,15,16,17. Our study also showed that, the intragastric flora diversity was significantly lower in the GP group than that in the HC group. Moreover, the composition of the intragastric flora in the two groups had significant differences. These findings showed that patients with gastric polyps have significantly different stomach flora than healthy people, and intragastric flora dysbiosis may be closely related to the occurrence and development of gastric polyps.
A recent study showed that gastric cancer patients had a higher abundance of Streptococcus and Fusobacterium species and a lower abundance of Acinetobacter species7. We found that gastric bacteria that were enriched in gastric cancer patients were also highly abundant in patients with gastric polyps, while gastric bacteria with low abundance in gastric cancer patients also had low abundance in patients with gastric polyps, suggesting that these bacteria may be associated with the occurrence of gastric polyps and the progression of gastric polyps to gastric cancer. However, there was also one study that was inconsistent with our conclusion. This study showed that in patients with gastric cancer, Rhodococcus, Clostridium, Lactobacillus, Citrobacter and Achromobacter were highly abundant, and Helicobacter, Streptococcus, Neisseria and Prevotella had low abundances6.
In addition, we found that both the HC and GP groups showed a high abundance of halophilic bacteria, such as Halomonas and Shewanella, which was not consistent with previous studies6,14,15,16,17. This may be related to the consumption of salty or pickled foods by Chinese individuals, as previous studies mainly focused on western countries. However, the abundance of halophilic bacteria in the GP group was significantly higher than that in the HC group, suggesting that eating preserved food or high-salt food may be a risk factor for gastric polyps.
Previous studies have suggested that the stomach flora compositions of the gastric body, gastric antrum, lesions and non-mucosal lesions are similar7,14,18, but this result is controversial19,20. Our study found that in both the HC group and the GP group, the flora compositions in different sites (gastric antrum, gastric body and gastric polyps) were similar, and the flora diversity between different tissue subgroups of the same group were also similar, indicating that the composition of stomach bacteria may not be related to the location or even the lesion. This is consistent with previous studies. Our study also found that although there was no significant difference between the gastric antrum and the gastric body or between the normal and diseased mucosa, the flora composition difference in different sites of GP group was larger than the difference observed in HCs. In addition, the individual differences in the GP group were also larger than the individual differences in the HC group. This indicates that the intragastric flora in patients with gastric polyps was more variable than that in HCs, which further confirmed that gastric polyps in patients are associated with gastric flora dysbiosis.
In our study, all subjects in the HC group were H. pylori-negative in the stomach as determined by a routine clinical test. However, after high-throughput sequencing, we found that H. pylori DNA was detected in all subjects in both groups. This is primarily because the high-throughput sequencing method based on bacterial 16S rDNA is more sensitive than the traditional clinical H. pylori detection methods, and it can detect H. pylori sequences with extremely low abundance in the stomach14. Our study showed that the gastric microbiota compositions were different according to H. pylori abundance, especially that H. pylori-high subjects had a much higher relative abundance of Helicobacter than H. pylori-low subjects. Notably, the H. pylori abundance in the stomach could affect the composition of the intragastric flora. This conclusion was similar to previous studies21,22. In addition, our study showed that the H. pylori abundance in the HC group was significantly higher than that in the GP group, however, the H. pylori abundance could not distinct FGP and HP. These results suggested that the presence of H. pylori may be inversely associated with the occurrence of FGP and HP. In other words, the presence of H. pylori may be a protective factor for these benign gastric polyps. This result was consistent with previously published data which reported that the presence of fundic gland polyps was inversely correlated with H. pylori infection3,23.
In this study, MDI was calculated based on the significantly different genera in the HC and GP groups, and the HC and GP groups could be distinguished clearly with the AUC reaching 0.918, and the accuracy and precision of verification reached 93.2% and 100%, respectively. The MDI index could be used as a biomarker of microbial indicators of GP in future clinical applications and it may predict people who have the tendency of having GP. However, there was only a small validation set of data used to assess the performance of this index in the present study, and a larger number of samples are needed to validate this predictive index.
There were several limitations in this study. The population size was not large, and the number of samples assigned to the subgroups was relatively small; thus, a larger number of samples are required to validate the results of this study. Analysis of 16S rDNA can only discriminate to the genus level with limited accuracy, and more specific sequencing and analysis techniques are required to determine which bacterial species or strains are involved in the pathogenesis of GP. In addition, this study only analyzed the stomach bacteria, and whether the stomach contains fungi or viruses and the effects of their changes require further study.
The diversity of the gastric flora in patients with gastric polyps was significantly lower than that of healthy people, and the intragastric bacterial composition between the two groups was significantly different. However, flora compositions in different parts of the stomach (gastric antrum, gastric body or polyp tissue) were similar. H. pylori could alter the structure of the gastric microbiota. The MDI we designed was able to differentiate between the healthy and polyp groups, but further validation with a larger population is needed.
Material and Methods
This study was conducted at the Chinese PLA General Hospital, Beijing, China. From May 2012 to December 2013, consecutive patients with gastric polyposis (GP) were recruited. All patients were diagnosed by gastroscopy and pathology at the first visit and did not receive any treatment. As healthy controls (HCs), we selected subjects that had no gastrointestinal symptoms, tested negative for H. pylori with the rapid urease test (RUT), and had normal gastric mucosal morphology based on a physical check-up. Demographics, H. pylori infection status and medications were assessed. This study was carried out according to the Helsinki Declaration and written informed consent was obtained from all subjects. This study was approved by the ethics committee of the Chinese PLA General Hospital and was registered with the WHO ICTRP (ID: ChiCTR-OCC-12002573).
To be eligible for participation in this study, all subjects were required to meet the following inclusion criteria: (1) adult male or female; (2) of Han nationality from the northern areas of China; (3) able and willing to provide gastric mucosal biopsy samples; and (4) able and willing to provide signed informed consent. GP patients were confirmed with histological analysis of gastric mucosal biopsy samples. Subjects who met any of the following criteria were excluded from this study: (1) having taken antibiotics, proton pump inhibitors (PPIs), non-steroidal anti-inflammatory drugs (NSAIDs), probiotics, prebiotics, corticosteroids, chemotherapy drugs or any other drugs that affect the gastrointestinal microbiota within the last month; (2) diagnosed with acute or chronic pulmonary, cardiovascular, hepatic or renal disorders; (3) positive for human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) or hepatitis V virus; (4) a history of major surgery; and (5) pregnant or lactating.
Collection of gastric mucosal biopsy samples
All subjects were fasting and were not taking drugs that affect the gastrointestinal flora when they underwent gastroscopy. The gastric mucosal biopsy samples were obtained with standard and sterilized endoscopy forceps. To avoid contamination, new sterilized endoscopy forceps were used when taking a second biopsy from the same subject. For individuals in the HC group, two normal gastric mucosal biopsy samples from the gastric antrum and body were collected and labeled HC.A and HC.B, respectively. For patients in the GP group, two gastric mucosal biopsy samples from the normal gastric antrum and body were collected and labeled GP.A and GP.B, respectively, one polyposis tissue sample was collected and labeled GP.P, and polyposis was confirmed by histology. The biopsy samples were frozen in liquid nitrogen immediately, transferred to laboratory and stored at −80 °C.
DNA extraction and PCR amplification
Total genome DNA from samples was extracted using the QIAamp DNA Mini Kit (QIAGEN, Valencia, CA, USA) combined with the bead-beating method14. The DNA concentrations of each sample were adjusted to 50 ng/μl for subsequent 16S rDNA genes analysis. The bacterial DNA was stored at –80 °C for sequencing.
16S rDNA genes of V4 region were amplified used universal primers (F: 5′-GTGCCAGCMGCCGCGGTAA-3′, R: 5′-GGACTACHVGGGTWTCTAAT-3′) with a 6-bp barcode. All PCR reactions (including denaturation, annealing and elongation) were carried out with Phusion® High-Fidelity PCR Master Mix (New England Biolabs). After electrophoresis of PCR products, samples with bright main strip between 400–450 bp were chosen for next mixing and purification with Qiagen Gel Extraction Kit (Qiagen, Germany). At last, sequencing libraries were generated and sequenced on an Illumina MiSeq PE-300 platform (Illumina, San Diego, USA). Barcodes and sequencing primers were trimmed before assembly.
16S rDNA gene sequencing data analysis
Paired-end reads were merged using FLASH (V1.2.7, http://ccb.jhu.edu/software/FLASH/)24 and raw tags were obtained. Then quality filtering on the raw tags was done with QIIME (V1.7.0, http://qiime.org/index.html)25 to obtain the high-quality clean tags26. These trimmed sequences were then chimera filtered, and singletons were discarded, and the sequences were assigned to operational taxonomic units (OTUs) (with a cutoff of 97% sequence identity for 16S rDNA) using the Uparse pipeline (V7.0.1001, http://drive5.com/uparse/)27,28,29. For each representative sequence of OTU was screened and aligned against the non-redundant SILVA database (version 123) using the RDP algorithm (V 2.2, http://sourceforge.net/projects/rdp-classifier)30. Alpha- and beta- analyses were performed using observed OTUs and Unifrac distances, respectively, as implemented in QIIME (V1.7.0).
All statistical analysis was conducted with the program R software (version 3.4.1), using the packages vegan, stat, pROC. Spearman rank correlation coefficient was used to assess the correlation between taxonomic relative abundance. Significance differences in alpha diversity, beta diversity and taxonomy between groups were tested using Wilcoxon rank-sum test. Continuous data were presented as the mean ± SD and analyzed by the Student’s t test (P < 0.05). And categorical data were analyzed by the Chi-square test (P < 0.05). Similarity index were statistic between two different samples, based on counts at each sample. The formula is as follows:
Cij is the sum of the lesser values for only those species in common between both sites. Si and Sj are the total number of specimens counted at both sites.
PCoA was employed to determine differences between microbial communities using weighted and unweighted unifrac dissimilarity distance metric. NMDS analysis was performed with the Vegan package (version 2.4-4) in R software.
This study was approved by the Regional Ethical Review Board of the Chinese PLA General Hospital.
Carmack, S. W., Genta, R. M., Schuler, C. M. & Saboorian, M. H. The current spectrum of gastric polyps: a 1- year national study of over 120000 patients. Am J Gastroenterol 104, 1524–32 (2009).
Cao, H., Wang, B., Zhang, Z., Zhang, H. & Qu, R. Distribution trends of gastric polyps: an endoscopy database analysis of 24121 northern Chinese patients. J Gastroenterol Hepatol 27, 1175–80 (2012).
Sonnenberg, A. & Genta, R. M. Prevalence of benign gastric polyps in a large pathology database. Dig Liver Dis 47, 164–169 (2015).
Fixa, B., Vanasek, T., Volfova, M., Nozicka, J. & Nozicka, Z. Cystic polyposis of the stomach (fundic gland polyps)-relationship to the absence of Helicobacter pylori infection and a therapy with drugs suppressing gastric acidity. Cas Lek Cesk 151, 196–200 (2012).
Hongo, M. & Fujimoto, K., Gastric Polyps Study Group.. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gstroenterol 45, 618–624 (2010).
Ferreira, R. M. et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut 67, 226–236 (2018).
Coker, O. O. et al. Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut 67, 1024–1032 (2018).
Shen, X. J. et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut microbes 1, 138–47 (2010).
Scanlan, P. D. et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environmental microbiology 10, 789–98 (2008).
Dejea, C. M. et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359, 592–597 (2018).
Kim, J. et al. An appropriate cutoff value for determining the colonization of helicobacter pylori by the pyrosequencing method: comparison with conventional methods. Helicobacter 20, 370–80 (2015).
Gevers, D. et al. The treatment-naïve microbiome in new-onset Crohn’s disease. Cell Host Microbe 15, 382–92 (2014).
Marshall, B. J. & Warren, J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311–1315 (1984).
Bik, E. M. et al. Molecular analysis of the bacterial microbiota in the human stomach. Proceedings of the National Academy of Sciences of the United States of America 103, 732–7 (2006).
Li, X. X. et al. Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PloS one 4, e7985 (2009).
Andersson, A. F. et al. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PloS one 3, e2836 (2008).
Stearns, J. C. et al. Bacterial biogeography of the human digestive tract. Scientific reports 1, 170 (2011).
Li, T. H. et al. Alterations in Gastric Microbiota After H. Pylori Eradication and in Different Histological Stages of Gastric Carcinogenesis. Scientific reports 7, 44935 (2017).
Yu, G. et al. Gastric microbiota features associated with cancer risk factors and clinical outcomes: A pilot study in gastric cardia cancer patients from Shanxi, China. Int. J. Cancer 141, 45–51 (2017).
Yu, G. et al. Molecular Characterization of the Human Stomach Microbiota in Gastric Cancer Patients. Frontiers in cellular and infection microbiology 7, 302 (2017).
Llorca, L. et al. Characterization of the gastric microbiota in a pediatric population according to Helicobacter pylori. Pediatr Infect Dis J 36, 173–178 (2017).
Klymiuk, I. et al. The human gastric microbiome is predicated upon infection with Helicobacter pylori. Front Microbiol 8, 2508 (2017).
Genta, R. M., Schuler, C. M., Robiou, C. I. & Lash, R. H. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. Clin Gastroenterol Hepatol 7, 849–54 (2009).
Magoc, T. & Salzberg, S. L. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957–63 (2011).
Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods 7, 335–6 (2010).
Bokulich, N. A. et al. Quality-filtering vastly improves diversity estimates from Illuminaamplicon sequencing. Nature methods 10, 57–59 (2013).
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194–200 (2011).
Haas, B. J. et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome research 21, 494–504 (2011).
Edgar, R. C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nature methods 10, 996–8 (2013).
Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Applied and environmental microbiology 73, 5261–5267 (2007).
This work was supported the National High Technology Research and Development Program of China (863 Program, ID: 2015AA02701). We thank AJE (www.aje.com) for its linguistic assistance during the preparation of this manuscript.
The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Ren, R., Wang, Z., Sun, H. et al. The gastric mucosal-associated microbiome in patients with gastric polyposis. Sci Rep 8, 13817 (2018). https://doi.org/10.1038/s41598-018-31738-2
- Gastric Polyposis (GP)
- Gastric Microbiota
- Gastric Flora
- Fundic Gland Polyps (FGPs)
- Gastric Body
Changes of the Gastric Mucosal Microbiome Associated With Histological Stages of Gastric Carcinogenesis
Frontiers in Microbiology (2020)
Frontiers in Microbiology (2020)
Critical Reviews in Oncology/Hematology (2019)